Prothrombin complex concentrates in trauma and perioperative bleeding

Anesthesiology

Volumn 122, Issue 4, 2015, Pages 923-931

  Grottke, Oliver ^a   Levy, Jerrold H ^b  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; ANTIVITAMIN K; BIOLOGICAL MARKER; FIBRINOGEN; FIBRINOGEN CONCENTRATE; FRESH FROZEN PLASMA; PROTHROMBIN; PROTHROMBIN COMPLEX; THROMBOCYTE CONCENTRATE; BLOOD CLOTTING FACTOR; PROTHROMBIN COMPLEX CONCENTRATES;

BLOOD CLOTTING; BLOOD CLOTTING TIME; CARDIOVASCULAR SURGERY; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG COST; DRUG EFFICACY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; ERYTHROCYTE TRANSFUSION; FIBRIN FORMATION; FIBRINOGEN DEFECT; HUMAN; HYPOTHERMIA; INJURY; INJURY SCALE; INTERNATIONAL NORMALIZED RATIO; MONOTHERAPY; NONHUMAN; NOTE; OPERATIVE BLOOD LOSS; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL (TOPIC); THROMBOCYTE TRANSFUSION; THROMBOEMBOLISM; ANIMAL; DRUG EFFECTS; PATHOPHYSIOLOGY; WOUNDS AND INJURIES;

ANIMALS; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; HUMANS; POSTOPERATIVE HEMORRHAGE; WOUNDS AND INJURIES;

EID: 84932115507     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0000000000000608     Document Type: Note

References (40)

1. Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G; American College of Chest Physicians: Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133(6 suppl):160-98S
2. Tazarourte K, Riou B, Tremey B, Samama CM, Vicaut E, Vigué B; EPAHK Study Group: Guideline-concordant administration of prothrombin complex concentrate and vitamin K is associated with decreased mortality in patients with severe bleeding under vitamin K antagonist treatment (EPAHK study). Crit Care 2014; 18:R81
3. Dentali F, Imberti D, Tamburini Permunian E, Croci E, Ageno W: Risk factors for suboptimal efficacy of 3-factor prothrombin complex concentrates in emergency VKA anticoagulation reversal. Thromb Haemost 2014; 112:621-3
4. Hiippala ST, Myllylä GJ, Vahtera EM: Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 1995; 81:360-5
5. Dunbar NM, Chandler WL: Thrombin generation in trauma patients. Transfusion 2009; 49:2652-60
6. Rourke C, Curry N, Khan S, Taylor R, Raza I, Davenport R, Stanworth S, Brohi K: Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. J Thromb Haemost 2012; 10:1342-51
7. Solomon C, Rahe-Meyer N, Sørensen B: Fibrin formation is more impaired than thrombin generation and platelets immediately following cardiac surgery. Thromb Res 2011; 128:277-82
8. Görlinger K, Dirkmann D, Hanke AA, Kamler M, Kottenberg E, Thielmann M, Jakob H, Peters J: First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: A retrospective, single-center cohort study. Anesthesi ology 2011; 115:1179-91
9. Weber CF, Zacharowski K, Meybohm P, Adam EH, Hofer S, Brün K, Volk T, Kreuer S: Hemotherapy algorithms for coagulopathic cardiac surgery patients. Clin Lab 2014; 60:1059-63
10. Schöchl H, Voelckel W, Grassetto A, Schlimp CJ: Practical application of point-of-care coagulation testing to guide treatment decisions in trauma. J Trauma Acute Care Surg 2013; 74:1587-98
11. Kozek-Langenecker SA, Afshari A, Albaladejo P, Santullano CA, De Robertis E, Filipescu DC, Fries D, Görlinger K, Haas T, Imberger G, Jacob M, Lancé M, Llau J, Mallett S, Meier J, Rahe-Meyer N, Samama CM, Smith A, Solomon C, Van der Linden P, Wikkelsø AJ, Wouters P, Wyffels P: Management of severe perioperative bleeding: Guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 2013; 30:270-382
12. Grottke O, Braunschweig T, Spronk HM, Esch S, Rieg AD, van Oerle R, ten Cate H, Fitzner C, Tolba R, Rossaint R: Increasing concentrations of prothrombin complex concentrate induce disseminated intravascular coagulation in a pig model of coagulopathy with blunt liver injury. Blood 2011; 118:1943-51
13. Levy JH, Tanaka KA, Dietrich W: Perioperative hemostatic management of patients treated with vitamin K antagonists. Anesthesi ology 2008; 109:918-26
14. Mitterlechner T, Innerhofer P, Streif W, Lödl M, Danninger T, Klima G, Hansson K, Fries D: Prothrombin complex concentrate and recombinant prothrombin alone or in combination with recombinant factor X and FVIIa in dilutional coagulopathy: A porcine model. J Thromb Haemost 2011; 9:729-37
15. Hanker Dusel C, Grundmann C, Eich S, Seitz R, König H: Identification of prothrombin as a major thrombogenic agent in prothrombin complex concentrates. Blood Coagul Fibrinolysis 2004; 15:405-11
16. Rodgers GM: Prothrombin complex concentrates in emergency bleeding disorders. Am J Hematol 2012; 87:898-902
17. Dickneite G, Doerr B, Kaspereit F: Characterization of the coagulation deficit in porcine dilutional coagulopathy and substitution with a prothrombin complex concentrate. Anesth Analg 2008; 106:1070-7
18. Dickneite G, Pragst I: Prothrombin complex concentrate vs fresh frozen plasma for reversal of dilutional coagulopathy in a porcine trauma model. Br J Anaesth 2009; 102:345-54
19. Kaspereit F, Hoffmann S, Pragst I, Dickneite G: Prothrombin complex concentrate mitigates diffuse bleeding after cardiopulmonary bypass in a porcine model. Br J Anaesth 2010; 105:576-82
20. Pragst I, Kaspereit F, Dörr B, Dickneite G: Prothrombin complex concentrate (Beriplex P/N) for control of bleeding after kidney trauma in a rabbit dilutional coagulopathy model. Thromb Res 2010; 125:272-7
21. Honickel M, Rieg A, Rossaint R, Braunschweig T, Spronk HM, ten Cate H, van Oerle R, Tolba R, Grottke O: Prothrombin complex concentrate reduces blood loss and enhances thrombin generation in a pig model with blunt liver injury under severe hypothermia. Thromb Haemost 2011; 106:724-33
22. Porta CR, Nelson D, McVay D, Salgar S, Eckert M, Izenberg S, Martin MJ: The effects of tranexamic acid and prothrombin complex concentrate on the coagulopathy of trauma: An in vitro analysis of the impact of severe acidosis. J Trauma Acute Care Surg 2013; 75:954-60
23. Bruce D, Nokes TJ: Prothrombin complex concentrate (Beriplex P/N) in severe bleeding: Experience in a large tertiary hospital. Crit Care 2008; 12:R105
24. Schick KS, Fertmann JM, Jauch KW, Hoffmann JN: Prothrombin complex concentrate in surgical patients: Retrospective evaluation of vitamin K antagonist reversal and treatment of severe bleeding. Crit Care 2009; 13:R191
25. Arnékian V, Camous J, Fattal S, Rézaiguia-Delclaux S, Nottin R, Stéphan F: Use of prothrombin complex concentrate for excessive bleeding after cardiac surgery. Interact Cardiovasc Thorac Surg 2012; 15:382-9
26. Schöchl H, Nienaber U, Hofer G, Voelckel W, Jambor C, Scharbert G, Kozek-Langenecker S, Solomon C: Goaldirected coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 2010; 14:R55
27. Schöchl H, Nienaber U, Maegele M, Hochleitner G, Primavesi F, Steitz B, Arndt C, Hanke A, Voelckel W, Solomon C: Transfusion in trauma: Thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. Crit Care 2011; 15:R83
28. Innerhofer P, Westermann I, Tauber H, Breitkopf R, Fries D, Kastenberger T, El Attal R, Strasak A, Mittermayr M: The exclusive use of coagulation factor concentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt trauma. Injury 2013; 44:209-16
29. Görlinger K, Fries D, Dirkmann D, Weber CF, Hanke AA, Schöchl H: Reduction of fresh frozen plasma requirements by perioperative point-of-care coagulation management with early calculated goal-directed therapy. Transfus Med Hemother 2012; 39:104-13
30. Josi D, Hoffer L, Buchacher A, Schwinn H, Frenzel W, Biesert L, Klöcking HP, Hellstern P, Rokicka-Milewska R, Klukowska A: Manufacturing of a prothrombin complex concentrate aiming at low thrombogenicity. Thromb Res 2000; 100:433-41
31. Ostermann H, Haertel S, Knaub S, Kalina U, Jung K, Pabinger I: Pharmacokinetics of Beriplex P/N prothrombin complex concentrate in healthy volunteers. Thromb Haemost 2007; 98:790-7
32. Pabinger I, Brenner B, Kalina U, Knaub S, Nagy A, Ostermann H; Beriplex P/N Anticoagulation Reversal Study Group: Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: A prospective multinational clinical trial. J Thromb Haemost 2008; 6:622-31
33. Riess HB, Meier-Hellmann A, Motsch J, Elias M, Kursten FW, Dempfle CE: Prothrombin complex concentrate (Octaplex) in patients requiring immediate reversal of oral anticoagulation. Thromb Res 2007; 121:9-16
34. Wiedermann CJ, Stockner I: Warfarin-induced bleeding complications-Clinical presentation and therapeutic options. Thromb Res 2008; 122(suppl 2):S13-8
35. Koster A, Meyer-Jark T, Schirmer U, Sandica E: Fulminant intraoperative right heart and pulmonary artery thrombosis following prothrombin complex concentrate infusion after complex open heart surgery with cardiopulmonary bypass. A A Case Rep 2014; 2:89-91
36. Hanke AA, Joch C, Görlinger K: Long-term safety and efficacy of a pasteurized nanofiltrated prothrombin complex concentrate (Beriplex P/N): A pharmacovigilance study. Br J Anaesth 2013; 110:764-72
37. Schlimp CJ, Solomon C, Keibl C, Zipperle J, Nürnberger S, Ohlinger W, Redl H, Schöchl H: Recovery of fibrinogen concentrate after intraosseous application is equivalent to the intravenous route in a porcine model of hemodilution. J Trauma Acute Care Surg 2014; 76:1235-42
38. Schöchl H, Voelckel W, Maegele M, Kirchmair L, Schlimp CJ: Endogenous thrombin potential following hemostatic therapy with 4-factor prothrombin complex concentrate: A 7-day observational study of trauma patients. Crit Care 2014; 18:R147
39. Sørensen B, Spahn DR, Innerhofer P, Spannagl M, Rossaint R: Clinical review: Prothrombin complex concentrates-Evaluation of safety and thrombogenicity. Crit Care 2011; 15:201
40. Nielsen VG: Beyond cell based models of coagulation: Analyses of coagulation with clot "lifespan" resistance-time relationships. Thromb Res 2008; 122:145-52